Table 3 Association between LBMI and mortality at 3 months.

From: Impact of lean body mass index on short-term outcomes in patients with ischemic stroke: an observational cohort study

 

Events, n (%)

Age and sex-adjusted

MV-adjusted

MV and FMI-adjusted*

OR

(95% CI)

P

OR

(95% CI)

P

OR

(95% CI)

P

Q1 (8.5–15.8), n = 2685

126 (4.7)

1.00

(reference)

 

1.00

(reference)

 

1.00

(reference)

 

Q2 (12.4–16.9), n = 2683

47 (1.8)

0.43

(0.31–0.61)

 < 0.001

0.47

(0.33–0.67)

 < 0.001

0.54

(0.37–0.80)

0.002

Q3 (13.3–17.9), n = 2684

34 (1.3)

0.35

(0.24–0.52)

 < 0.001

0.41

(0.27–0.61)

 < 0.001

0.51

(0.32–0.82)

0.006

Q4 (14.2–29.2), n = 2683

30 (1.1)

0.37

(0.24–0.56)

 < 0.001

0.42

(0.27–0.66)

 < 0.001

0.61

(0.34–1.08)

0.09

  1. The multivariable model included age, sex, hypertension, dyslipidemia, diabetes mellitus, smoking, drinking, atrial fibrillation, chronic kidney disease, history of stroke, stroke subtype (cardioembolism, small vessel occlusion, large artery atherosclerosis, or others), National Institutes of Health Stroke Scale score on admission, and reperfusion therapy.
  2. Mortality was defined as death from any cause 3 months after stroke onset. Lean body mass index (LBMI) was categorized into four groups according to quartiles by sex.
  3. CI, confidence interval; FMI, fat mass index; LBMI, lean body mass index; MV, multivariable; OR, odds ratio.
  4. *Fat mass index was added to the multivariable model.